Tag:

Baminercept

Latest Headlines

Latest Headlines

Biogen Idec drops baminercept for RA

Biogen Idec said it won't continue developing baminercept for rheumatoid arthritis after the drug failed to hit the primary or secondary endpoints in a Phase II trial. The primary endpoint was